{
    "id": "2181b0c4-5229-4371-96aa-184adeacc311",
    "result_metadata": {
        "score": 1
    },
    "copyright": "COPYRIGHT 2020 Plus Media Solutions",
    "geoOrigin": "Lahore, Pakistan",
    "sourceType": "Government Document",
    "source": "US Official News",
    "corpus_document_id": "18573480204674270198",
    "description": "Washington: U.S. Food and Drug Administration has issued the following drug shortage:. Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason. Vistaril 25 mg Capsules; 100 count bottle Next delivery and Estimated recovery: August 2020 Shortage per manufacturer: Manufacturing Delay Other.",
    "serviceName": "Gale All",
    "locationCode": [
        {
            "parent": "LR/am",
            "relevance_score": "9",
            "description": "North America",
            "code": "LB/nam#9#49#90",
            "level": 1
        },
        {
            "parent": "LB/nam",
            "relevance_score": "9",
            "description": "United States",
            "code": "LC/us#9#50#90",
            "level": 2
        },
        {
            "parent": null,
            "relevance_score": "9",
            "description": "Americas",
            "code": "LR/am#9#49#90",
            "level": 0
        },
        {
            "code": "LR/nam#9#49#90",
            "description": "",
            "relevance_score": "9"
        }
    ],
    "sourceClass": "Government Agencies (U.S.), Government Policy, Local Government, National Government",
    "subjectCode": [
        {
            "parent": null,
            "relevance_score": "9",
            "description": "Business and Commerce",
            "code": "IS/biz#9#50#99",
            "level": 0
        },
        {
            "parent": "IS/biz",
            "relevance_score": "9",
            "description": "Manufacturing Operations",
            "code": "IS/biz.man#9#99#50",
            "level": 1
        },
        {
            "parent": null,
            "relevance_score": "9",
            "description": "Health and Wellness",
            "code": "IS/haw#9#50#99",
            "level": 0
        },
        {
            "parent": "IS/haw.treat",
            "relevance_score": "9",
            "description": "Medicinal Drugs",
            "code": "IS/haw.drugs#9#99#50",
            "level": 2
        }
    ],
    "text": "Washington: U.S. Food and Drug Administration has issued the following drug\nshortage:\n\nFDA Drug Shortages\n\nHydroxyzine Pamoate Oral Capsules\n\nStatus: Currently in Shortage\n\n>>Date first posted: 03/12/2019\n\n>>Therapeutic Categories: Psychiatry\n\nHeritage Pharma (New 11/15/2019)\n\nImpax Laboratories (Reverified 02/20/2020)\n\nPfizer Pharmaceuticals (Revised 06/05/2020)\n\nCompany Contact Information:\n\n800-533-4535\n\nPresentation Availability and Estimated Shortage Duration Related Information\nShortage Reason (per FDASIA)\n\nVistaril (Hydroxyzine Pamoate Oral Capsules) 25 mg Capsules; 100 count bottle\n(NDC 0069-5410-66) Next delivery and Estimated recovery: August 2020 Shortage\nper manufacturer: Manufacturing Delay Other\n\nVistaril (Hydroxyzine Pamoate Oral Capsules) 50 mg Capsules; 100 count bottle\n(NDC 0069-5420-66) Available Other",
    "industryCode": [
        {
            "parent": null,
            "relevance_score": "9",
            "description": "Manufacturing",
            "code": "II/man#9#99#50",
            "level": 0
        },
        {
            "parent": "II/hcare.pharma",
            "relevance_score": "7",
            "description": "Drug Delivery Systems",
            "code": "II/hcare.drugdel#7#50#71",
            "level": 1
        },
        {
            "parent": "II/hcare.drugdel",
            "relevance_score": "7",
            "description": "Oral Drug Delivery",
            "code": "II/hcare.oral#7#71#50",
            "level": 2
        },
        {
            "parent": null,
            "relevance_score": "7",
            "description": "Pharmaceuticals",
            "code": "II/hcare.pharma#7#50#71",
            "level": 0
        }
    ],
    "naviga_enrichment": {
        "org": [
            "U.S. Food and Drug Administration",
            "Impax Laboratories",
            "Pfizer Pharmaceuticals"
        ],
        "location": [
            "Washington"
        ],
        "person": [],
        "companies": [
            "U.S. Food and Drug Administration",
            "Impax Laboratories",
            "Pfizer Pharmaceuticals"
        ]
    },
    "geoOrigin_code": "RU/pk..lahore",
    "language": "English",
    "filename": "202006080000GALE____PUB_ALL_626364078.XML",
    "providerName": "Gale Group",
    "enriched_text": {
        "entities": [
            {
                "count": 3,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "Hydroxyzine",
                "relevance": 0.868446,
                "type": "Drug"
            },
            {
                "count": 2,
                "sentiment": {
                    "score": -0.661357,
                    "label": "negative"
                },
                "text": "U.S. Food and Drug Administration",
                "relevance": 0.626741,
                "type": "Organization",
                "disambiguation": {
                    "subtype": [
                        "GovernmentAgency"
                    ],
                    "name": "Food and Drug Administration",
                    "dbpedia_resource": "http://dbpedia.org/resource/Food_and_Drug_Administration"
                }
            },
            {
                "count": 2,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "NDC",
                "relevance": 0.47245,
                "type": "Organization"
            },
            {
                "count": 1,
                "sentiment": {
                    "score": -0.515697,
                    "label": "negative"
                },
                "text": "Pfizer Pharmaceuticals",
                "relevance": 0.377409,
                "type": "Company",
                "disambiguation": {
                    "subtype": [],
                    "name": "Pfizer",
                    "dbpedia_resource": "http://dbpedia.org/resource/Pfizer"
                }
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "Impax Laboratories",
                "relevance": 0.367169,
                "type": "Company"
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "Heritage Pharma",
                "relevance": 0.330038,
                "type": "Company"
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "Washington",
                "relevance": 0.285747,
                "type": "Location",
                "disambiguation": {
                    "subtype": [
                        "City"
                    ]
                }
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "25 mg",
                "relevance": 0.285747,
                "type": "Quantity"
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "50 mg",
                "relevance": 0.285747,
                "type": "Quantity"
            }
        ],
        "semantic_roles": [
            {
                "subject": {
                    "text": "U.S. Food and Drug Administration"
                },
                "sentence": "Washington: U.S. Food and Drug Administration has issued the following drug",
                "object": {
                    "text": "issued the following drug"
                },
                "action": {
                    "verb": {
                        "text": "have",
                        "tense": "present"
                    },
                    "text": "has",
                    "normalized": "have"
                }
            },
            {
                "subject": {
                    "text": "U.S. Food and Drug Administration"
                },
                "sentence": "Washington: U.S. Food and Drug Administration has issued the following drug",
                "object": {
                    "text": "the following drug"
                },
                "action": {
                    "verb": {
                        "text": "issue",
                        "tense": "past"
                    },
                    "text": "has issued",
                    "normalized": "have issue"
                }
            }
        ],
        "categories": [
            {
                "score": 0.887748,
                "label": "/health and fitness"
            },
            {
                "score": 0.847115,
                "label": "/business and industrial/pharmaceutical industry"
            },
            {
                "score": 0.790274,
                "label": "/health and fitness/drugs"
            }
        ],
        "relations": [
            {
                "type": "locatedAt",
                "sentence": "Washington: U.S. Food and Drug Administration has issued the following drug shortage:",
                "score": 0.746626,
                "arguments": [
                    {
                        "text": "Washington",
                        "location": [
                            0,
                            10
                        ],
                        "entities": [
                            {
                                "type": "GeopoliticalEntity",
                                "text": "Washington"
                            }
                        ]
                    },
                    {
                        "text": "U.S.",
                        "location": [
                            12,
                            16
                        ],
                        "entities": [
                            {
                                "type": "GeopoliticalEntity",
                                "text": "U.S.",
                                "disambiguation": {
                                    "subtype": [
                                        "Country"
                                    ]
                                }
                            }
                        ]
                    }
                ]
            },
            {
                "type": "basedIn",
                "sentence": "Washington: U.S. Food and Drug Administration has issued the following drug shortage:",
                "score": 0.680025,
                "arguments": [
                    {
                        "text": "Food and Drug Administration",
                        "location": [
                            17,
                            45
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "Food and Drug Administration",
                                "disambiguation": {
                                    "subtype": [
                                        "Government"
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "text": "U.S.",
                        "location": [
                            12,
                            16
                        ],
                        "entities": [
                            {
                                "type": "GeopoliticalEntity",
                                "text": "U.S.",
                                "disambiguation": {
                                    "subtype": [
                                        "Country"
                                    ]
                                }
                            }
                        ]
                    }
                ]
            },
            {
                "type": "agentOf",
                "sentence": "Washington: U.S. Food and Drug Administration has issued the following drug shortage:",
                "score": 0.541047,
                "arguments": [
                    {
                        "text": "Food and Drug Administration",
                        "location": [
                            17,
                            45
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "Food and Drug Administration",
                                "disambiguation": {
                                    "subtype": [
                                        "Government"
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "text": "issued",
                        "location": [
                            50,
                            56
                        ],
                        "entities": [
                            {
                                "type": "EventCommunication",
                                "text": "issued"
                            }
                        ]
                    }
                ]
            },
            {
                "type": "employedBy",
                "sentence": "Vistaril (Hydroxyzine Pamoate Oral Capsules) 25 mg Capsules; 100 count bottle (NDC 0069-5410-66) Next delivery and Estimated recovery: August 2020 Shortage per manufacturer: Manufacturing Delay Other",
                "score": 0.536171,
                "arguments": [
                    {
                        "text": "Shortage",
                        "location": [
                            666,
                            674
                        ],
                        "entities": [
                            {
                                "type": "Person",
                                "text": "Shortage Duration"
                            }
                        ]
                    },
                    {
                        "text": "manufacturer",
                        "location": [
                            679,
                            691
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "manufacturer"
                            }
                        ]
                    }
                ]
            }
        ],
        "keywords": [
            {
                "text": "Hydroxyzine Pamoate Oral Capsules",
                "relevance": 0.730734,
                "count": 2
            },
            {
                "text": "Drug Administration",
                "relevance": 0.704698,
                "count": 1
            },
            {
                "text": "Presentation Availability",
                "relevance": 0.671814,
                "count": 1
            },
            {
                "text": "Next delivery",
                "relevance": 0.625792,
                "count": 1
            },
            {
                "text": "U.S. Food",
                "relevance": 0.614754,
                "count": 1
            },
            {
                "text": "NDC",
                "relevance": 0.590076,
                "count": 2
            },
            {
                "text": "Washington",
                "relevance": 0.570359,
                "count": 1
            },
            {
                "text": "Pfizer Pharmaceuticals",
                "relevance": 0.566298,
                "count": 1
            },
            {
                "text": "Impax Laboratories",
                "relevance": 0.566298,
                "count": 1
            },
            {
                "text": "Therapeutic Categories",
                "relevance": 0.566298,
                "count": 1
            },
            {
                "text": "Shortage",
                "relevance": 0.545516,
                "count": 2
            },
            {
                "text": "manufacturer",
                "relevance": 0.54237,
                "count": 1
            },
            {
                "text": "Company Contact Information",
                "relevance": 0.539352,
                "count": 1
            },
            {
                "text": "Date",
                "relevance": 0.525452,
                "count": 1
            },
            {
                "text": "recovery",
                "relevance": 0.521387,
                "count": 1
            },
            {
                "text": "Shortage Duration",
                "relevance": 0.50904,
                "count": 1
            },
            {
                "text": "mg Capsules",
                "relevance": 0.505989,
                "count": 2
            },
            {
                "text": "count bottle",
                "relevance": 0.468619,
                "count": 2
            },
            {
                "text": "Vistaril",
                "relevance": 0.4399,
                "count": 1
            },
            {
                "text": "August",
                "relevance": 0.380382,
                "count": 1
            },
            {
                "text": "FDASIA",
                "relevance": 0.376731,
                "count": 1
            },
            {
                "text": "New",
                "relevance": 0.376731,
                "count": 1
            }
        ]
    },
    "freqeuncy": "Daily",
    "extracted_metadata": {
        "sha1": "44ed32d69c5bcd72da74d4cc618f26607efaf364",
        "filename": "202006080000GALE____PUB_ALL_626364078.json",
        "file_type": "json"
    },
    "companyRecord": "Munich|ILR|ISIN:US45256B1017|Impax Laboratories Inc.|extractor|DUNS:002595734;NECOID:13108;ACORN:1076929792;UDUNS:081238827|MENTION||||XMUN|REFERENCE",
    "publicationTime": "2020-06-08T00:00:00-04:00",
    "title": "FDA drug shortage: Hydroxyzine Pamoate Oral Capsules (Currently in Shortage) June 05, 2020.",
    "html": "<p><location idsrc=\"xmltag.org\" value=\"LU/us.dc.wash\">Washington</location>: <org idsrc=\"xmltag.org\" value=\"ACORN:0682203466\">U.S. Food and Drug Administration</org> has issued the\nfollowing drug shortage:</p>\n\n<p>FDA Drug Shortages</p>\n\n<p>Hydroxyzine Pamoate Oral Capsules</p>\n\n<p>Status: Currently in Shortage</p>\n\n<p>&gt;&gt;Date first posted: <chron>03/12/2019</chron></p>\n\n<p>&gt;&gt;Therapeutic Categories: Psychiatry</p>\n\n<p>Heritage Pharma (New 11/15/2019)</p>\n\n<p><org idsrc=\"xmltag.org\" value=\"Munich:ILR\">Impax Laboratories</org> (Reverified 02/20/2020)</p>\n\n<p><org>Pfizer Pharmaceuticals</org> (Revised 06/05/2020)</p>\n\n<p>Company Contact Information:</p>\n\n<p>800-533-4535</p>\n\n<p>Presentation Availability and Estimated Shortage Duration Related\nInformation Shortage Reason (per FDASIA)</p>\n\n<p>Vistaril (Hydroxyzine Pamoate Oral Capsules) 25 mg Capsules; 100\ncount bottle (NDC 0069-5410-66) Next delivery and Estimated recovery:\n<chron>August 2020</chron> Shortage per manufacturer: Manufacturing Delay Other</p>\n\n<p>Vistaril (Hydroxyzine Pamoate Oral Capsules) 50 mg Capsules; 100\ncount bottle (NDC 0069-5420-66) Available Other</p>",
    "geoFocus": [
        [
            "GC/us",
            "United States"
        ]
    ]
}